Agilent Technologies, Inc. (A)
$
121.38
+0.72 (0.59%)
Key metrics
Financial statements
Free cash flow per share
4.9123
Market cap
34.5 Billion
Price to sales ratio
5.2021
Debt to equity
0.5696
Current ratio
2.0915
Income quality
1.3593
Average inventory
994 Million
ROE
0.1946
Technology
Technology – consumer electronics
Largecap
With a market cap of 121,78 bil stock is ranked 1
Low risk
ISS score of this stock is ranked 1
Company description
Profile
Agilent Technologies, Inc. provides application-focused solutions to life sciences, diagnostics, and applied chemical markets globally. The Life Sciences and Applied Markets segment delivers a wide array of analytical instruments and systems, including liquid chromatography systems and components, mass spectrometry systems, gas chromatography systems, and various spectroscopy technologies. The company's innovative approach is evident in its diverse offerings such as cell analysis plate-based assays, flow cytometers, laboratory automation tools, and dissolution testing equipment. Additionally, Agilent incurred an interest expense of $96,000,000.00 reflecting its debt servicing obligations. The gross profit ratio is 0.54 which highlights the efficiency of the company's production and sales operations. Furthermore, the diluted EPS is $4.43 accounting for potential share dilution, while the net income ratio stands at 0.20 demonstrating the company's profitability margin. The reported depreciation and amortization expenses amount to $257,000,000.00 underscoring the wear and tear of its assets. On the diagnostics front, Agilent offers advanced technologies for DNA analysis, including arrays for mutation detection and next-generation sequencing, along with reagents for turbidimetry. In addition, Agilent CrossLab segment delivers essential laboratory supplies and services such as custom chemistries and sample preparation products. The stock is reasonably priced at $120.45 appealing to a broad range of investors. With a high average trading volume of 2,162,537.00 there is strong liquidity in the stock, making it an attractive option for market participants. The company showcases a mid-range market capitalization of $34,479,809,700.00 positioning it as a steady performer within the sector. As a key player in the Medical - Diagnostics & Research industry, Agilent significantly contributes to the overall market landscape, driving innovation and growth within the Healthcare sector. Its comprehensive range of products is marketed through direct sales, distributors, and electronic commerce, ensuring a broad reach in delivering its advanced solutions to a global clientele.
Is Agilent Technologies, Inc. (A) a good investment?
Investing in Agilent Technologies, Inc. (A) depends on multiple factors, including revenue growth, profit margins, debt-to-equity ratio, earnings per share, and return on equity. Analysts have rated it as B+, with a Bullish outlook. Always conduct your own research before investing.
What is Agilent Technologies, Inc. (A)'s stock forecast?
Analysts predict Agilent Technologies, Inc. stock to fluctuate between $96.43 (low) and $153.84 (high) in the next 365 days, reflecting market expectations and potential volatility.
What is Agilent Technologies, Inc.'s market capitalization?
As of 2025-07-03, Agilent Technologies, Inc.'s market cap is $34,479,809,700, based on 284,065,000 outstanding shares.
How does Agilent Technologies, Inc. compare to competitors like Eli Lilly & Co.?
Compared to Eli Lilly & Co., Agilent Technologies, Inc. has a Lower Market-Cap, indicating a difference in performance.
Does Agilent Technologies, Inc. pay dividends?
Agilent Technologies, Inc. pays dividends. The current dividend yield is 0.81%, with a payout of $0.25 per share.
How can I buy Agilent Technologies, Inc. (A) stock?
To buy Agilent Technologies, Inc. (A) stock: Open a brokerage account (e.g., Robinhood, TD Ameritrade, E-Trade). Search for A. Place an order (Market, Limit, etc.).
What is the best time to invest in Agilent Technologies, Inc.?
The best time to invest depends on market trends and technical indicators, which show a Bullish trend based on economic conditions and company performance.
Has Agilent Technologies, Inc. stock ever split?
Agilent Technologies, Inc.'s last stock split was 699:500 on 2014-11-03.
How did Agilent Technologies, Inc. perform in the last earnings report?
Revenue: $6,510,000,000 | EPS: $4.44 | Growth: 5.21%.
Where can I find Agilent Technologies, Inc.'s investor relations reports?
Visit https://www.agilent.com/investor-relations for detailed financial reports.
Where can I find historical stock prices for Agilent Technologies, Inc.?
You can explore historical data from here
What is the all-time high and low for Agilent Technologies, Inc. stock?
All-time high: $179.57 (2021-09-03) | All-time low: $96.43 (2025-04-09).
What are the key trends affecting Agilent Technologies, Inc. stock?
Key trends include market demand, economic conditions, interest rates, and industry competition, which influence the stock's performance.
News
zacks.com
Agilent (A) reported earnings 30 days ago. What's next for the stock?
zacks.com
A's second-quarter fiscal 2025 results benefit from strong LC & services, but margin contraction raises investor concerns.
seekingalpha.com
Agilent Technologies, Inc. (NYSE:A ) Q2 2025 - Earnings Conference Call May 28, 2025 4:30 PM ET Company Participants Parmeet Ahuja – VP, IR Padraig McDonnell - President and CEO Robert W. McMahon - SVP and CFO Simon May - President of Life Sciences and Diagnostics Markets Group Angelica Riemann - President of Agilent CrossLab Group Mike Zhang - President of Applied Markets Group Conference Call Participants Patrick Donnelly - Citi Jack Meehan - Nephron Research Rachel Vatnsdal - JPMorgan Puneet Souda - Leerink Partners Vijay Kumar - Evercore ISI Tycho Peterson - Jefferies Brandon Couillard - Wells Fargo Michael Ryskin - Bank of America Dan Leonard - UBS Operator Good afternoon.
zacks.com
While the top- and bottom-line numbers for Agilent (A) give a sense of how the business performed in the quarter ended April 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
zacks.com
Agilent Technologies (A) came out with quarterly earnings of $1.31 per share, beating the Zacks Consensus Estimate of $1.26 per share. This compares to earnings of $1.22 per share a year ago.
reuters.com
Agilent Technologies beat Wall Street estimates for second-quarter profit and revenue on Wednesday, helped by strong demand for its tools and equipment used in drug development, sending its shares up 5.1% in extended trading.
businesswire.com
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced August Specht, Ph.D., has been named the company's Chief Technology Officer. Specht, previously vice president of Global R&D for the Chromatography and Mass Spectrometry Division at Thermo Fisher Scientific, will join Agilent on June 9. “We are thrilled to welcome August Specht to the Agilent team as we further accelerate the pace of innovation in an ever-changing world through our Ignite Transformatio.
businesswire.com
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced that Pascal Soriot, CEO of AstraZeneca, and Judy Gawlik Brown, founder and CEO of Downtown Advisory, have been elected to its Board of Directors, effective May 21, 2025. Soriot and Gawlik Brown bring decades of global leadership experience across the pharmaceutical, biotechnology, and health-care sectors, with proven track records in strategy, innovation, operations, and finance. Pascal Soriot has led Astr.
zacks.com
Agilent (A) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
seekingalpha.com
This month's preferred stock IPO market is frozen, dominated by “Par Cross” and “Insider Buying” alerts, reflecting investor uncertainty due to trade tensions. The trade war and tariffs have created significant market volatility, causing companies to withdraw earnings guidance and defer investment decisions. Preferred stocks and baby bonds offer fixed payments, making them attractive during uncertain times, as they provide a “known return” amidst market unpredictability.
See all news
